PHK
ALDR

Point72 Hong Kong’s Alder Biopharmaceuticals ALDR Stock Holding History

Point72 Hong Kong’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,217
Closed -$38K – 1532
2019
Q2 		$38K Buy
3,217
+2,262
+237% +$27.4K 0.01% 671
2019
Q1 		$13K Buy
+955
New +$12.4K 0.01% 736
2018
Q3 		– Sell
-3,833
Closed -$61K – 1337
2018
Q2 		$61K Buy
+3,833
New +$58.2K 0.02% 393
2017
Q3 		– Sell
-6,766
Closed -$77K – 1175
2017
Q2 		$77K Buy
+6,766
New +$125K 0.08% 146

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Hong Kong's ALDR Position: Q3 2019 in Review

Point72 Hong Kong sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 3,217 shares — an estimated $38K sold.

Point72 Hong Kong first reported a position in ALDR in Q2 2017 and held it in 4 quarters. The position peaked at $77K in Q2 2017. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • Point72 Hong Kong reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Point72 Hong Kong sold 3,217 Alder Biopharmaceuticals shares in Q3 2019, an estimated $38K.
  • Point72 Hong Kong first reported a position in Alder Biopharmaceuticals in Q2 2017 and held it in 4 quarters.
  • Point72 Hong Kong's Alder Biopharmaceuticals position peaked at $77K in Q2 2017.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on Point72 Hong Kong's 13F filing for Q3 2019, filed 14 Nov 2019.